Additionally, a multi-tracer study longitudinally tracking microglial activation and glucose hypometabolism simultaneously in a transgenic mouse model of Alzheimer’s disease observed discrepancies between the data trend of the TSPO-tracer [18F]GE-180 and [18F]FDG [36]. This evidence concerns the gene TSPO and Alzheimer disease.